Sriparna Roy

1 week ago | marketscreener.com | Sriparna Roy

(Reuters) -The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than two-year-long review process. This makes Leqembi the first approved drug in the European Union that targets an underlying cause of the fatal mind-wasting disease. It had been under regulatory review since January 2023.

1 week ago | today.westlaw.com | Sriparna Roy |Alan Barona |Manas Mishra |Shreya Biswas

(Reuters) -The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than two-year-long review process.

1 week ago | flipboard.com | Sriparna Roy

1 week ago | dagenspharma.dk | Sriparna Roy |Shailesh Kuber |Shilpi Majumdar

The logo of Danish drugmaker Novo Nordisk in their offices in Hillerod, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain in the United States. The country's health regulator seized the counterfeit injections on April 9 and is investigating them.

3 weeks ago | ksl.com | Sriparna Roy |Mariam Sunny |Puyaan Singh |Julie Steenhuysen |Deena Beasley

SEMINOLE, Texas — Texas and New Mexico health departments said on Friday that the number of measles cases in their states rose 20% since their last reports three days ago, as experts warn they expect the outbreak to further spread in coming weeks. Texas now has 400 cases, the Texas Department of State Health Services said, 270 of which were in Gaines County, where the current measles outbreak started. Texas has reported two deaths from measles since this outbreak began.